© Springer International Publishing Switzerland 2015
Lawrence M. Friedman, Curt D. Furberg, David L. DeMets, David M. Reboussin and Christopher B. GrangerFundamentals of Clinical Trials10.1007/978-3-319-18539-2_23
Erratum

Erratum

Lawrence M. Friedman, Curt D. Furberg2, David L. DeMets3, David M. Reboussin4 and Christopher B. Granger5
(1)
North Bethesda, MD, USA
(2)
Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA
(3)
Department Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI, USA
(4)
Department of Biostatistics, Wake Forest School of Medicine, Winston-Salem, NC, USA
(5)
Department of Medicine, Duke University, Durham, NC, USA
 
The updated original online version for this chapter can be found at 10.​1007/​978-3-319-18539-2_​17
In the original publication on page vi, there is a typographical error in the print and online versions of this book. “Principal” was incorrectly spelled as “Principle.”
Corrections to chapter 17, page 381, follow, and these changes have been updated in the book.
Chapter 17
Statistical Methods Used in Interim Monitoring
p 381
Many different spending functions can be specified. The O’Brien–Fleming α 1(t*) and Pocock α 2 (t*) type spending functions are specified as follows:
 $$ \begin{array}{ll}{\alpha}_1\left(t^{*}\right)=2-2\Phi \left({Z}_{\alpha / 2}/\sqrt{t^{*}}\right)\hfill & \sim \mathrm{O}'\mathrm{Brien}\hbox{-} \mathrm{Fleming}\hfill \\ {}{\alpha}_2\left(t^{*}\right)=\alpha\ \ln \left(1+\Big(e-1\right)t^{*}\Big)\hfill & \sim \mathrm{Pocock}\hfill \\ {}{\alpha}_3\left(t^{*}\right)=\alpha\ {t^{*}}^{\theta}\hfill & \mathrm{for} \ \theta >0\hfill \end{array} $$
The spending function α3(t*) spends alpha uniformly during the trial for θ = 1, at a rate somewhat between α1(t*) and α2(t*). Other spending functions have also been defined [75, 76].